The most recent colloidal silver scientific research, clinical studies and more.


Written by Dr. Robert J Rowen on his official Facebook page – November 30th 2014
Dear Facebook Family,
You all have been devoted to our mission, and therefore you all should be the first to know the most fabulous news you will hear regarding the Ebola crisis. Dr. Robert Rowen and Dr. Howard Robins now openly announce to the world the first CONFIRMED case of Ebola which has been apparently cured with the Rowen-Robins Ebola protocol, which features the Robins method of DIV ozone administration.
If you’ve been reading the news, Dr. Komba Songu M’Briwa, a senior military physician in Sierra Leone, and one who had been with the now deceased Dr. Salia, contracted the disease, likely from embracing Dr. Salia when Salia’s first test came back negative. Dr. M’Briwa made international news on November 27, 2014 with the announcement that he contracted Ebola.…/af1fbd54-7627-11e4-a755-e32…
Dr. M’Briwa was presented with the offer of our ozone protocol, and signed the informed consent. This is the email Rowen got on November 27, 2014, from Dr. M. Jalloh, who became the managing physician of this case:
“Hello Dr. Rowen, This is Dr. M I Jalloh the guy who brought you the tennis shoes at Hastings [Ebola treatment center]. Hope you are fine.
I am not the one directly treating Dr. Songu M’brewa but I coordinate his treatment. He is presently stable with no diarrhea or vomiting. He is receiving the ozone (55 mls) twice a day. He is also receiving Advanced Cellular Silver (ACS 200), Vitamin C and Glutathione. The management is promising. They will probably run another Ebola test after ten doses of ozone to check if he is still positive and the viral load…Will keep you updated.”

Dr. Jalloh has indeed kept us updated. Today, November 30, only 3 days later, Dr. Jalloh has informed Dr. Rowen that Dr. M’Briwa promptly resolved his fever and had no further development of the usual Ebola symptoms of horror. In fact, he’s already been moved out of the Ebola sick unit into the “recovery” unit. Furthermore, a second test (for viral load) after treatment commenced was negative for Ebola, and a third test will be performed on Monday, December 1. You will be sure the naysayers will, like they often do when a confirmed cancer case “mysteriously” recovers at the hands of unconventional doctors, that they might say the same here. But it will be hard to do on this one. He had direct contact with Dr. Salia, he was personally treating Ebola, and he was housed in the Ebola treatment unit after testing positive. No one will be able to deny this one. And, he recovered exactly as we predicted would be the course of ozone-treated Ebola.
Now, here is an interesting twist to the story. You will remember our announcement of the first doctor we reported who jabbed himself with an infected needle? That was Dr. Sekou Kanneh, who was scared for his livelihood and life should he get a positive test, be quarantined, and then be denied ozone. Dr. Kanneh was the hands-on treating physician for Dr. M’Briwa, and was supervised in the program by Dr. Jalloh.
And finally, today, Dr. Rowen spontaneously got a delightful email from someone he didn’t recognize. It said, “Hi Dr . Its been a while since u left sierra Leone. How are u doing? We miss d ozone therapy.” When an email was sent inquiring as to the identity of the sender, this returned: “Am d head nurse nurse at Hastings ebola treatment centre. U gave me your email d last time u went there. Actually, we are taking ozone but my colleagues at other treatment centres around d country are not .
Sent from my BlackBerry® smartphone from Airtel Sierra Leone.
This appears to be the most promising advance in the Ebola crisis, and we are hopeful that everything we are being told from our sources is accurate. We are anxiously awaiting additional information regarding Dr. M’Briwa (and Dr. Kanneh). Folks, we wish to thank you for your support, your prayers and your love. We are bringing this case to the world now, and you can certainly help by getting it to news media, friends and family.
Sincerely, Robert Rowen, MD and Howard Robins, DPM



Results RNA Publishes Video Showing Efficacy Comparison of 5 Major Brands

The core purpose of every silver-based health product is to kill pathogenic microorganisms. To this effect, independent laboratory studies prove that not all colloidal silver brands are equal. Four out of the five colloidal silver brands tested in a recent antimicrobial study had very little effect on the microorganisms tested. While one colloidal silver brand achieved complete in vitro kill against MRSA, Borrelia burgdorferi (Lyme) Candida and more. See video above for more information. We encourage all colloidal silver manufacturers to increase research and testing to provide better quality products to health practitioners and the public, and to then submit any scientific research documents and media to us.

Drug-Resistant Superbug Infections: 500% Increase across U.S. Hospitals!

“We’re in the post-antibiotic era.

Dr. Arjun Srinivasan, associate director at the Centers for Disease Control and Prevention

Drug-resistant superbug infections have reached near-epidemic levels across U.S. hospitals, with an alarming 500% increase now documented in a study just published in the August issue of Infection Control and Hospital Epidemiology (the journal of the Society for Healthcare Epidemiology of America).(1)

The CDC has admitted that we are now living in a “post-antibiotics era.” As Infection Control Today states, “Antibiotic resistance is no longer a prediction for the future. It is happening right now in every region of the world and has the potential to affect anyone.” (2)

Dr. Arjun Srinivasan, associate director at the Centers for Disease Control and Prevention, went even further in a PBS interview, stating: (3)

“We’ve reached the end of antibiotics, period… We’re here. We’re in the post-antibiotic era. There are patients for whom we have no therapy, and we are literally in a position of having a patient in a bed who has an infection, something that five years ago even we could have treated, but now we can’t.

Protect your patients and your practice.

Sources for this newsletter include: